systemic%20lupus%20erythematosus%20(pediatric)
SYSTEMIC LUPUS ERYTHEMATOSUS (PEDIATRIC)
Systemic lupus erythematosus is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation.
It can be suspected when ≥2 organ systems are involved.
It is predominantly diagnosed in females of childbearing age, rarely diagnosed before 8 years old.
Clinical presentation varies in different patients and the disease activity varies over time in a single patient. Majority of patients have arthralgia of the hand.
Drug Information

Indication: Relief of inflammatory & pruritic manifestations of steroid-responsive dermatoses eg, psoriasis (excluding...

Indication: Eczema including atopic, infantile, discoid & stasis eczema; prurigo; psoriasis; neurodermatoses including...

Indication: Short-term treatment of corticosteroid-responsive resistant dermatoses eg, psoriasis, recalcitrant eczema, lic...

Indication: Symptomatic treatment of allergic dermatoses & other forms of contact dermatitis, insect bites; atopic, ec...

Indication: Reducing disease activity in adult patients w/ active autoantibody +ve SLE receiving standard therapy.

Indication: Relief of inflammatory manifestations of corticosteroid-responsive dermatoses.

Indication: Suppression of skin diseases in which inflammation is a prominent feature.

Indication: Suppression of skin diseases in which inflammation is a prominent feature.

Indication: Relief of inflammatory & pruritic manifestations of corticosteroid-responsive dermatoses (eg, psoriasis, e...

Indication: Acute & chronic rheumatic fever, RA, bronchial asthma, myositis, dermatitis.

1  /  6
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Stephen Padilla, 02 Oct 2019
Baseline body mass index (BMI) and, to a lesser extent, school socioeconomic status are associated with subsequent weight status in schoolchildren, according to a study. Lifestyle behaviours show a lower effect as compared with prior BMI, but children with a healthier lifestyle have a reduced risk of overweight and obesity at follow-up.
04 Sep 2019
The use of iron-fortified formula milk in infants between 6–12 months of age may lead to poorer cognitive outcomes, a recent study has shown.
Audrey Abella, 07 May 2019
Use of electronic vapour products (EVP), or vaping, has been associated with an increased likelihood of engaging in sexual and substance-use risk behaviours among US teenagers, according to data from the 2017 National Youth Risk Behaviour Survey presented at the Paediatric Academic Societies (PAS) 2019 Meeting.
Jairia Dela Cruz, 04 Sep 2019
Parenteral antibiotic therapy duration for bacteraemic urinary tract infection (UTI) in young infants may be safely shortened, according to a recent study showing that recurrence and readmission or emergency department revisitation rates are comparable between a ≤7-day and a longer therapy course.